$RMTI
ROCKWELL MEDICAL, INC. Stock $rmti

$rmti Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-Q Financial Statement

#000162828024035859 Filed on August 08, 2024

Income Statement

Concept	2024 Q3	2024 Q2
Revenue	$28.32M	$25.83M
YoY Change	19.12%	42.88%
Cost Of Revenue	$22.08M	$21.28M
YoY Change	2.36%	24.84%
Gross Profit	$6.239M	$4.550M
YoY Change	183.33%	340.46%
Gross Profit Margin	22.03%	17.61%
Selling, General & Admin	$4.303M	$4.035M
YoY Change	24.91%	5.49%
% of Gross Profit	68.97%	88.68%
Research & Development	$0.00	$0.00
YoY Change	-100.0%	-100.0%
% of Gross Profit	0.0%	0.0%
Depreciation & Amortization	$400.0K	$400.0K
YoY Change	0.0%	100.0%
% of Gross Profit	6.41%	8.79%
Operating Expenses	$4.303M	$4.035M
YoY Change	9.24%	1.08%
Operating Profit	$1.936M	$515.0K
YoY Change	-211.46%	-117.4%
Interest Expense	-$272.0K	-$172.0K
YoY Change	-166.18%	-143.54%
% of Operating Profit	-14.05%	-33.4%
Other Income/Expense, Net	-$272.0K	-$172.0K
YoY Change	101.48%	-50.29%
Pretax Income	$1.664M	$343.0K
YoY Change	-188.89%	-110.38%
Income Tax
% Of Pretax Income
Net Earnings	$1.664M	$343.0K
YoY Change	-188.89%	-110.38%
Net Earnings / Revenue	5.88%	1.33%
Basic Earnings Per Share	$0.05	$0.01
Diluted Earnings Per Share	$0.04	$0.01
COMMON SHARES
Basic Shares Outstanding	31.03M shares	30.32M shares
Diluted Shares Outstanding	32.42M shares	32.03M shares

Balance Sheet

Concept	2024 Q3	2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$18.27M	$11.86M
YoY Change	55.77%	-20.2%
Cash & Equivalents	$12.34M	$11.86M
Short-Term Investments	$5.934M	$0.00
Other Short-Term Assets	$1.171M	$1.167M
YoY Change	-26.63%	-20.88%
Inventory	$5.888M	$5.883M
Prepaid Expenses
Receivables	$8.886M	$10.84M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$34.22M	$29.75M
YoY Change	21.45%	7.94%
LONG-TERM ASSETS
Property, Plant & Equipment	$5.795M	$6.009M
YoY Change	-14.41%	187.1%
Goodwill	$921.0K	$921.0K
YoY Change	0.0%	0.0%
Intangibles	$10.35M	$10.48M
YoY Change	-5.07%
Long-Term Investments
YoY Change
Other Assets	$548.0K	$548.0K
YoY Change	3.98%	3.98%
Total Long-Term Assets	$22.87M	$23.28M
YoY Change	-6.41%	122.26%
TOTAL ASSETS
Total Short-Term Assets	$34.22M	$29.75M
Total Long-Term Assets	$22.87M	$23.28M
Total Assets	$57.08M	$53.03M
YoY Change	8.51%	39.41%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.607M	$3.347M
YoY Change	-33.65%	-43.53%
Accrued Expenses	$6.290M	$6.168M
YoY Change	-6.23%	63.91%
Deferred Revenue	$46.00K	$46.00K
YoY Change	0.0%	-82.24%
Short-Term Debt	$469.0K	$670.0K
YoY Change	-3.89%	-8.59%
Long-Term Debt Due	$587.0K	$576.0K
YoY Change	-89.58%	-87.56%
Total Short-Term Liabilities	$14.18M	$14.89M
YoY Change	-33.77%	-14.67%
LONG-TERM LIABILITIES
Long-Term Debt	$8.383M	$8.295M
YoY Change	151.67%	75.0%
Other Long-Term Liabilities	$14.00K	$14.00K
YoY Change	0.0%	0.0%
Total Long-Term Liabilities	$8.397M	$8.309M
YoY Change	151.03%	74.78%
TOTAL LIABILITIES
Total Short-Term Liabilities	$14.18M	$14.89M
Total Long-Term Liabilities	$8.397M	$8.309M
Total Liabilities	$27.95M	$29.53M
YoY Change	-10.1%	3.58%
SHAREHOLDERS EQUITY
Retained Earnings	-$396.9M	-$398.6M
YoY Change	0.31%	1.21%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$29.14M	$23.50M
YoY Change
Total Liabilities & Shareholders Equity	$57.08M	$53.03M
YoY Change	8.51%	39.41%

Cashflow Statement

Concept	2024 Q3	2024 Q2
OPERATING ACTIVITIES
Net Income	$1.664M	$343.0K
YoY Change	-188.89%	-110.38%
Depreciation, Depletion And Amortization	$400.0K	$400.0K
YoY Change	0.0%	100.0%
Cash From Operating Activities	$4.275M	$1.442M
YoY Change	-214.03%	-183.06%
INVESTING ACTIVITIES
Capital Expenditures	$191.0K	$286.0K
YoY Change	-98.46%	281.33%
Acquisitions
YoY Change
Other Investing Activities	-$5.921M	$2.003M
YoY Change	-383.44%	15307.69%
Cash From Investing Activities	-$6.112M	$1.717M
YoY Change	-40.62%	-2869.35%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	2.313M	2.065M
YoY Change	-81.99%	-1676.34%
NET CHANGE
Cash From Operating Activities	4.275M	1.442M
Cash From Investing Activities	-6.112M	1.717M
Cash From Financing Activities	2.313M	2.065M
Net Change In Cash	476.0K	5.224M
YoY Change	-139.73%	-370.81%
FREE CASH FLOW
Cash From Operating Activities	$4.275M	$1.442M
Capital Expenditures	$191.0K	$286.0K
Free Cash Flow	$4.084M	$1.156M
YoY Change	-125.33%	-163.83%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	46000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	475000	usd
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2024Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2000000	shares
CY2023Q4	us-gaap	Preferred Stock Value Outstanding PreferredStockValueOutstanding	0	usd
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	170000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	29130607	shares
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-397198000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	21291000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	52173000	usd
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Period End Date DocumentPeriodEndDate	2024-06-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity Registrant Name EntityRegistrantName	ROCKWELL MEDICAL, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Address Address Line1 EntityAddressAddressLine1	30142 S. Wixom Road
	dei	Entity Address City Or Town EntityAddressCityOrTown	Wixom
	dei	Entity Address State Or Province EntityAddressStateOrProvince	MI
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	48393
	dei	City Area Code CityAreaCode	248
	dei	Local Phone Number LocalPhoneNumber	960-9009
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Trading Symbol TradingSymbol	RMTI
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2024Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	31030218	shares
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.01
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	16795673	shares
	dei	Entity Central Index Key EntityCentralIndexKey	0001041024
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2023Q4	us-gaap	Contract With Customer Refund Liability Current ContractWithCustomerRefundLiabilityCurrent	243000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	16637000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1433000	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	8293000	usd
CY2023Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	2500000	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	14000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	30882000	usd
CY2024Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	15000	shares
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	31030218	shares
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	37748000	usd
	us-gaap	Gross Profit GrossProfit	3632000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	445000	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1028000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6545000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-4386000	usd
	us-gaap	Debt Securities Available For Sale Realized Gain Loss DebtSecuritiesAvailableForSaleRealizedGainLoss	0	usd
	us-gaap	Investment Income Net InvestmentIncomeNet	113000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-669000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-5055000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-5055000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	21291000	usd
CY2024Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	15000	shares
	dei	Document Period End Date DocumentPeriodEndDate	2024-06-30
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	0	usd
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	38-3317208
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
	dei	Security12b Title Security12bTitle	Common Stock, par value $0.0001
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	8983000	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	1952000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	10901000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	5871000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1063000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	28770000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	6402000	usd
CY2023Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	178000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2713000	usd
CY2023Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	1903000	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	10759000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	921000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	527000	usd
CY2023Q4	us-gaap	Assets Assets	52173000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	4516000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	7149000	usd
CY2023Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	2500000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1381000	usd
CY2023Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	558000	usd
CY2023Q4	us-gaap	Short Term Bank Loans And Notes Payable ShortTermBankLoansAndNotesPayable	244000	usd
CY2023Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	1530000	usd
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	31030218	shares
CY2023Q4	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	3000	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	418487000	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	34116000	usd
	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	782000	usd
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.27
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.27
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	18480248	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	18480248	shares
	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	0	usd
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-21000	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-4000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-5080000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-1731000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	25000	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	247000	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	251000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	20643000	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	343000	usd
CY2024Q2	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	25000	usd
CY2024Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-4000	usd
CY2024Q2	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	338000	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	23498000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	14106000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-1750000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-3000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-4000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	193000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	12542000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-3305000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-18000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-1000	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	309000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	9528000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-5055000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1094000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	330000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	589000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	502000	usd
	rmti	Operating And Finance Lease Right Of Use Asset Amortization Expense OperatingAndFinanceLeaseRightOfUseAssetAmortizationExpense	941000	usd
	rmti	Operating And Finance Lease Right Of Use Asset Amortization Expense OperatingAndFinanceLeaseRightOfUseAssetAmortizationExpense	1017000	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	249000	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	184000	usd
	us-gaap	Debt Securities Available For Sale Realized Gain Loss DebtSecuritiesAvailableForSaleRealizedGainLoss	51000	usd
	us-gaap	Debt Securities Available For Sale Realized Gain Loss DebtSecuritiesAvailableForSaleRealizedGainLoss	0	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-61000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-848000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	12000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	0	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-545000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-998000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1169000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1874000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-676000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-744000	usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-1098000	usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-3968000	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-23000	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-1602000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-938000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5616000	usd
	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	0	usd
	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	3835000	usd
	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	2003000	usd
	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	9298000	usd
	rmti	Payments To Acquire Machinery And Equipment Excluding Cash Paid In Asset Acquisition PaymentsToAcquireMachineryAndEquipmentExcludingCashPaidInAssetAcquisition	425000	usd
	rmti	Payments To Acquire Machinery And Equipment Excluding Cash Paid In Asset Acquisition PaymentsToAcquireMachineryAndEquipmentExcludingCashPaidInAssetAcquisition	225000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	1578000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	5238000	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	244000	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	503000	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	276000	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	258000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	2763000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2243000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-761000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-3000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-4000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	2880000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1143000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	8983000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	10102000	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	11863000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	8959000	usd
	us-gaap	Interest Paid Net InterestPaidNet	432000	usd
	us-gaap	Interest Paid Net InterestPaidNet	295000	usd
	rmti	Warrant Issued WarrantIssued	247000	usd
	rmti	Warrant Issued WarrantIssued	0	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	1549000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	0	usd
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	-21000	usd
	us-gaap	Notes Assumed1 NotesAssumed1	670000	usd
	us-gaap	Notes Assumed1 NotesAssumed1	733000	usd
	rmti	Area Of Operating Space AreaOfOperatingSpace	175000	sqft
CY2024Q2	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	11900000	usd
CY2024Q2	rmti	Working Capital Net WorkingCapitalNet	14900000	usd
	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that may affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</span></div>
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	343000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-3305000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1388000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-5055000	usd
CY2024Q2	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	-58000	usd
CY2023Q2	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	0	usd
	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	0	usd
	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	0	usd
CY2024Q2	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	285000	usd
CY2024Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	285000	usd
CY2023Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-3305000	usd
CY2023Q2	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-3305000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1388000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-1388000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-5055000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-5055000	usd
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	30451622	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	18496640	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	29889413	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	18480248	shares
CY2024Q2	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock	1363636	shares
CY2023Q2	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock	0	shares
	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock	0	shares
	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock	0	shares
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	32033776	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	18496640	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	29889413	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	18480248	shares
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.18
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.05
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.27
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.01
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.18
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.05
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.27
CY2024Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4327706	shares
CY2023Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	13444459	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	7778351	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	13444459	shares
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
	rmti	Average Payment Term Of Customers AveragePaymentTermOfCustomers	P30D
	rmti	Average Payment Term Of Distributors AveragePaymentTermOfDistributors	P60D
	rmti	Number Of Distribution And License Agreements NumberOfDistributionAndLicenseAgreements	5	agreement
CY2024Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	25832000	usd
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	48508000	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	18080000	usd
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	37748000	usd
CY2024Q2	us-gaap	Accounts Receivable Net AccountsReceivableNet	10840000	usd
CY2023Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	10901000	usd
CY2023Q1	us-gaap	Accounts Receivable Net AccountsReceivableNet	6259000	usd
CY2024Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	498000	usd
CY2023Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	521000	usd
CY2023Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	4331000	usd
CY2023Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	0	usd
CY2024Q2	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	0	usd
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	1600000	usd
CY2024Q2	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	500000	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest After Allowance For Credit Loss DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss	1948000	usd
CY2023Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	4000	usd
CY2023Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	0	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Accrued Interest After Allowance For Credit Loss DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss	0	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	1952000	usd
CY2024Q2	us-gaap	Debt Securities Available For Sale Realized Gain Loss DebtSecuritiesAvailableForSaleRealizedGainLoss	100000	usd
	us-gaap	Debt Securities Available For Sale Realized Gain Loss DebtSecuritiesAvailableForSaleRealizedGainLoss	100000	usd
CY2024Q2	us-gaap	Inventory Raw Materials InventoryRawMaterials	2209000	usd
CY2023Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	2250000	usd
CY2024Q2	us-gaap	Inventory Work In Process InventoryWorkInProcess	225000	usd
CY2023Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	351000	usd
CY2024Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	3449000	usd
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	3270000	usd
CY2024Q2	us-gaap	Inventory Gross InventoryGross	5883000	usd
CY2023Q4	us-gaap	Inventory Gross InventoryGross	5871000	usd
CY2024Q2	us-gaap	Inventory Noncurrent InventoryNoncurrent	178000	usd
CY2023Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	178000	usd
CY2024Q2	rmti	Inventory Current And Noncurrent InventoryCurrentAndNoncurrent	6061000	usd
CY2023Q4	rmti	Inventory Current And Noncurrent InventoryCurrentAndNoncurrent	6049000	usd
CY2024Q2	us-gaap	Inventory Gross InventoryGross	5900000	usd
CY2023Q4	us-gaap	Inventory Gross InventoryGross	5900000	usd
CY2024Q2	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	25000	usd
CY2023Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	25000	usd
CY2024Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	15632000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	15206000	usd
CY2024Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	9623000	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	8804000	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	6009000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	6402000	usd
CY2024Q2	us-gaap	Depreciation Depreciation	400000	usd
CY2023Q2	us-gaap	Depreciation Depreciation	200000	usd
	us-gaap	Depreciation Depreciation	800000	usd
	us-gaap	Depreciation Depreciation	300000	usd
CY2024Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1629000	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	2413000	usd
CY2024Q2	rmti	Accrued Unvouchered Receipts Current AccruedUnvoucheredReceiptsCurrent	1325000	usd
CY2023Q4	rmti	Accrued Unvouchered Receipts Current AccruedUnvoucheredReceiptsCurrent	1663000	usd
CY2024Q2	rmti	Accrued Manufacturing Expense Current AccruedManufacturingExpenseCurrent	902000	usd
CY2023Q4	rmti	Accrued Manufacturing Expense Current AccruedManufacturingExpenseCurrent	1064000	usd
CY2024Q2	us-gaap	Workers Compensation Liability Current WorkersCompensationLiabilityCurrent	408000	usd
CY2023Q4	us-gaap	Workers Compensation Liability Current WorkersCompensationLiabilityCurrent	254000	usd
CY2024Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1904000	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1755000	usd
CY2024Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	6168000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	7149000	usd
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2000000	shares
CY2024Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2000000	shares
CY2024Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	15000	shares
CY2024Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	15000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	15000	shares
CY2024Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	15000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	170000000	shares
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	170000000	shares
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	31030218	shares
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	31030218	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	29130607	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	29130607	shares
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	31030218	shares
CY2024Q2	rmti	Common Stock And Pre Funded Warrants Shares Outstanding CommonStockAndPreFundedWarrantsSharesOutstanding	31030218	shares
CY2023Q2	rmti	Common Stock And Pre Funded Warrants Shares Outstanding CommonStockAndPreFundedWarrantsSharesOutstanding	18588673	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1895031	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1570599	shares
CY2024Q2	us-gaap	Convertible Preferred Stock Shares Reserved For Future Issuance ConvertiblePreferredStockSharesReservedForFutureIssuance	1363636	shares
CY2023Q2	us-gaap	Convertible Preferred Stock Shares Reserved For Future Issuance ConvertiblePreferredStockSharesReservedForFutureIssuance	1363636	shares
CY2024Q2	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	38808569	shares
CY2023Q2	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	32033132	shares
CY2024Q2	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2023Q2	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2024Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	338000	usd
CY2023Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	309000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	589000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	502000	usd
CY2018Q4	rmti	Number Of Additional Agreements NumberOfAdditionalAgreements	3	agreement
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	1500000	usd
CY2024Q2	us-gaap	Operating Lease Expense OperatingLeaseExpense	341000	usd
CY2023Q2	us-gaap	Operating Lease Expense OperatingLeaseExpense	455000	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	761000	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	859000	usd
CY2024Q2	us-gaap	Variable Lease Cost VariableLeaseCost	128000	usd
CY2023Q2	us-gaap	Variable Lease Cost VariableLeaseCost	109000	usd
	us-gaap	Variable Lease Cost VariableLeaseCost	250000	usd
	us-gaap	Variable Lease Cost VariableLeaseCost	224000	usd
CY2024Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	469000	usd
CY2023Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	564000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	1011000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	1083000	usd
CY2024Q2	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	141000	usd
CY2023Q2	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	141000	usd
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	282000	usd
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	282000	usd
CY2024Q2	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	29000	usd
CY2023Q2	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	38000	usd
	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	61000	usd
	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	77000	usd
CY2024Q2	rmti	Finance Lease Expense FinanceLeaseExpense	170000	usd
CY2023Q2	rmti	Finance Lease Expense FinanceLeaseExpense	179000	usd
	rmti	Finance Lease Expense FinanceLeaseExpense	343000	usd
	rmti	Finance Lease Expense FinanceLeaseExpense	359000	usd
CY2024Q2	us-gaap	Short Term Lease Cost ShortTermLeaseCost	6000	usd
CY2023Q2	us-gaap	Short Term Lease Cost ShortTermLeaseCost	4000	usd
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	11000	usd
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	8000	usd
CY2024Q2	us-gaap	Lease Cost LeaseCost	645000	usd
CY2023Q2	us-gaap	Lease Cost LeaseCost	747000	usd
	us-gaap	Lease Cost LeaseCost	1365000	usd
	us-gaap	Lease Cost LeaseCost	1450000	usd
CY2024Q2	us-gaap	Operating Lease Payments OperatingLeasePayments	426000	usd
CY2023Q2	us-gaap	Operating Lease Payments OperatingLeasePayments	478000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	863000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	902000	usd
CY2024Q2	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	29000	usd
CY2023Q2	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	38000	usd
	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	61000	usd
	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	77000	usd
CY2024Q2	rmti	Cash Flows From Finance Lease Principal Payments CashFlowsFromFinanceLeasePrincipalPayments	138000	usd
CY2023Q2	rmti	Cash Flows From Finance Lease Principal Payments CashFlowsFromFinanceLeasePrincipalPayments	129000	usd
	rmti	Cash Flows From Finance Lease Principal Payments CashFlowsFromFinanceLeasePrincipalPayments	276000	usd
	rmti	Cash Flows From Finance Lease Principal Payments CashFlowsFromFinanceLeasePrincipalPayments	258000	usd
CY2024Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y7M6D
CY2023Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y8M12D
CY2024Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y7M6D
CY2023Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y8M12D
CY2024Q2	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P3Y
CY2023Q2	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P3Y10M24D
CY2024Q2	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P3Y
CY2023Q2	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P3Y10M24D
CY2024Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.063
CY2023Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.065
CY2024Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.063
CY2023Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.065
CY2024Q2	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.064
CY2023Q2	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.064
CY2024Q2	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.064
CY2023Q2	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.064
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	835000	usd
CY2024Q2	us-gaap	Finance Lease Liability Payments Remainder Of Fiscal Year FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear	334000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1587000	usd
CY2024Q2	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	676000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	946000	usd
CY2024Q2	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	666000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	525000	usd
CY2024Q2	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	311000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	2000	usd
CY2024Q2	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	0	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	3895000	usd
CY2024Q2	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	1987000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	295000	usd
CY2024Q2	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	175000	usd
CY2024Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	3600000	usd
CY2024Q2	us-gaap	Finance Lease Liability FinanceLeaseLiability	1812000	usd
CY2024Q2	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0001628280-24-035859-index-headers.html	Edgar Link	pending
0001628280-24-035859-index.html	Edgar Link	pending
0001628280-24-035859.txt	Edgar Link	pending
0001628280-24-035859-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
rmti-20240630.htm	Edgar Link	pending
rmti-20240630.xsd	Edgar Link	pending
rmti-20240630x10qex311.htm	Edgar Link	pending
rmti-20240630x10qex321.htm	Edgar Link	pending
Show.js	Edgar Link	pending
rmti-20240630_def.xml	Edgar Link	unprocessable
rmti-20240630_lab.xml	Edgar Link	unprocessable
rmti-20240630_pre.xml	Edgar Link	unprocessable
rmti-20240630_htm.xml	Edgar Link	completed
FilingSummary.xml	Edgar Link	unprocessable
rmti-20240630_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$RMTI
ROCKWELL MEDICAL, INC. Stock $rmti

2024 Q3 Form 10-Q Financial Statement

#000162828024035859 Filed on August 08, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$RMTI ROCKWELL MEDICAL, INC. Stock $rmti

2024 Q3 Form 10-Q Financial Statement

#000162828024035859 Filed on August 08, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$RMTI
ROCKWELL MEDICAL, INC. Stock $rmti